

Fundamental dimension Equity attribute | AMWDPeer $48.090.00% Cap $700.7MP/E 41.1x QuantScore50/100 | ACELLeader $11.00▲+0.27% Cap $893.1MP/E 16.2x QuantScore61/100 | AEVAPeer $10.17▲+2.94% Cap $708.9MP/E -50.9x QuantScore43/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
65/100 |
60/100 |
16/100 |
Valuation Multiples, PEG & DCF upside | 79/100 | 91/100 | 31/100 |
Health Piotroski, Altman Z, leverage & liquidity | 56/100 | 46/100 | 23/100 |
Growth Revenue / earnings growth & margins | 0/100 | 42/100 | 68/100 |
Sentiment Analyst ratings, targets & revisions | 50/100 | 64/100 | 75/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 41.1x | 16.2x | -50.9x |
Forward P/E (next FY) | 20.9x | 15.7x | -6.5x |
EV / EBITDA (TTM) | 11.3x | 5.9x | 10.3x |
Price / Sales | 0.5x | 0.6x | 32.8x |
Price / Free Cash Flow | 17.6x | 5.3x | -6.1x |
PEG ratio | -0.50 | 0.25 | -0.23 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 8 / 9 | 3 / 9 |
Altman Z-Score | 2.48 (Grey) | 2.78 (Grey) | -1.24 (Distress) |
Total debt / equity | 0.54 | 2.02 | 3.72 |
Quick ratio | 1.1x | 2.4x | 7.6x |
Interest coverage | 4.2x | 3.3x | -53.8x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -7.5% | +8.1% | +99.4% |
Net income growth YoY | -14.4% | +46.0% | +4.5% |
Gross margin (TTM) | 15.3% | 31.8% | 27.2% |
Operating margin (FY) | 8.2% | 8.2% | -705.8% |
FCF margin (FY) | 4.0% | 4.7% | -662.0% |
5. Trailing price performancePrice change over period |
1M return | 0.0% | -0.4% | -34.9% |
3M return | +19.9% | -8.6% | -31.5% |
6M return | -12.4% | -10.6% | -37.1% |
Year to date | -10.8% | -3.6% | -23.4% |
1Y return | -9.6% | +5.0% | -41.1% |
3Y return | -33.4% | +6.7% | +253.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $126.82 +163.7% upside | $11.65 +5.9% upside | $-10.03 -198.7% premium |
Wall Street consensus target | $69.50 +44.5% · range $46.00–$110.00 | $14.33 +30.3% · range $14.00–$15.00 | $28.75 +182.7% · range $20.00–$42.00 |
Consensus stance | 10% Buy90% Hold0% Sell | 67% Buy33% Hold0% Sell | 75% Buy25% Hold0% Sell |